In the post-pandemic era, the global respiratory health market has witnessed an unprecedented surge. From human healthcare to intensive livestock farming, the demand for effective respiratory support—ranging from supplementary oils and herbal extracts to broad-spectrum antibiotics—is at an all-time high. The industry is currently valued at billions of dollars, with a projected CAGR of over 6.5% through 2030.
Global procurement needs have shifted from simple reactive treatments to proactive immune-boosting solutions. Industrial-scale poultry and swine farms in Southeast Asia, South America, and Europe are increasingly seeking Chinese manufacturing expertise to stabilize their supply chains against diseases like Avian Influenza (ND Flu) and various mycoplasma infections.
As a leading China-based factory, we provide specialized solutions like our Pet Cough Immune Liquid Food Supplement, designed for global pet care distributors requiring consistent quality and high efficacy for wheezing and cough relief.
1. Natural Integration: There is a significant move toward "Green Medicine." Global buyers are prioritizing products like Cardamine Pratensis Flower Powder and Mullein Drops that offer lung detoxification without the side effects of synthetic compounds.
2. Precision Veterinary Care: Industrial farming is demanding more targeted delivery systems. Water-soluble powders like our 20% Doxycycline Hydrochloride are becoming the standard for rapid intervention in mass-poultry sets.
3. Supply Chain Resilience: Multinational pharmaceutical companies are decentralizing their sourcing, looking for "China Best" factories that hold comprehensive certifications like GMP, ISO, and FAMI-QS to ensure compliance with strict international regulation standards.
Our high-purity 20% Doxycycline Hydrochloride Soluble Powder epitomizes the trend of precision dosing, ensuring maximum bioavailability while minimizing waste in industrial agricultural applications.
China remains the world's powerhouse for API (Active Pharmaceutical Ingredients) production. Our three massive production bases in Shandong, Zhejiang, and Hebei provide the vertical integration necessary to control costs and ensure 100% purity from raw material to finished product.
We don't just manufacture; we understand the local challenges. Whether it's respiratory infections in the humid poultry farms of Brazil or immune support needs in the urban domestic pet markets of North America, our formulations are optimized for specific regional environmental stressors.
Leveraging modern pharmaceutical technology, Xian QLU Health Pharmaceutical Technology Co., Ltd. uses AI modeling to predict molecular stability and optimize the synergy between herbal extracts and traditional pharmaceutical ingredients, creating the next generation of respiratory support.
Xian QLU Health Pharmaceutical Technology Co., Ltd. engaged in the development, production and marketing of pharmaceutical products, food ingredients, vitamins, intermediates and chemicals.
QLU headquartered in Xian, China, with 3 production bases in Shandong, Zhejiang and Hebei separately, which have many years of experience in the production of APIs, vitamins and chemical products. These facilities have been certified GMP, ISO, FAMI-QS, KOSHER, HALAL, etc. We have complete control over our product development, design, and manufacturing processes, thanks to our advanced equipment, methods, and inspection facilities.
With key competencies in pharmaceuticals and food health, QLU Pharma has established extensive business networks around the world. We have Strategic Marketing Partners respectively in Mumbai and Dubai. We are ready to provide you with our best products and services.
In the ever-changing pharmaceutical industry, the spirit of QLU is characterized by flexibility and adaptability. We embrace emerging technologies, actively adopt new scientific advancements, and continuously evolve to meet the evolving needs of patients and healthcare providers.
QLU Health
